Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clain

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Digestive Diseases and Sciences|March 8, 2011
Detection of esophageal varices using CT and MRIMichael J Lipp, Arkady Broder, David Hudesman, et al.
Hepatitis Research and Treatment|December 29, 2010
Retreatment of patients nonresponsive to pegylated interferon and ribavirin with daily high-dose consensus interferonDouglas F Meyer, Hillel Tobias, Albert D Min, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 25, 2016
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in FranceN Argy, G I Bertin, J Milet, et al.
Journal of Affective Disorders|October 14, 2016
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressantsDavid Mischoulon, Lindsay Hylek, Albert S Yeung, et al.
Journal of Affective Disorders|November 4, 2017
Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]D Mischoulon, L Hylek, A S Yeung, et al.
Asian Journal of Psychiatry|December 30, 2014
Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study GroupJustin A Chen, Sagar Vijapura, George I Papakostas, et al.
Journal of Health Care for the Poor and Underserved|August 19, 2014
Race/ethnicity and other social determinants of psychological well-being and functioning in mental health clinicsTrina E Chang, Anthony P Weiss, Luana Marques, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Correlation between beta-lipoprotein levels and outcome of hepatitis C treatmentKavitha Gopal, Timothy C Johnson, Saraswathi Gopal, et al.
International Clinical Psychopharmacology|April 20, 2010
Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcomeAmy H Farabaugh, Stella Bitran, Janet Witte, et al.
Frontiers in Psychiatry|September 25, 2018
Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major DepressionJohannes A C Laferton, Sagar Vijapura, Lee Baer, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Digestive Diseases and Sciences|March 8, 2011
Detection of esophageal varices using CT and MRIMichael J Lipp, Arkady Broder, David Hudesman, et al.
Hepatitis Research and Treatment|December 29, 2010
Retreatment of patients nonresponsive to pegylated interferon and ribavirin with daily high-dose consensus interferonDouglas F Meyer, Hillel Tobias, Albert D Min, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 25, 2016
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in FranceN Argy, G I Bertin, J Milet, et al.
Journal of Affective Disorders|October 14, 2016
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressantsDavid Mischoulon, Lindsay Hylek, Albert S Yeung, et al.
Journal of Affective Disorders|November 4, 2017
Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]D Mischoulon, L Hylek, A S Yeung, et al.
Asian Journal of Psychiatry|December 30, 2014
Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study GroupJustin A Chen, Sagar Vijapura, George I Papakostas, et al.
Journal of Health Care for the Poor and Underserved|August 19, 2014
Race/ethnicity and other social determinants of psychological well-being and functioning in mental health clinicsTrina E Chang, Anthony P Weiss, Luana Marques, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Correlation between beta-lipoprotein levels and outcome of hepatitis C treatmentKavitha Gopal, Timothy C Johnson, Saraswathi Gopal, et al.
International Clinical Psychopharmacology|April 20, 2010
Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcomeAmy H Farabaugh, Stella Bitran, Janet Witte, et al.
Frontiers in Psychiatry|September 25, 2018
Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major DepressionJohannes A C Laferton, Sagar Vijapura, Lee Baer, et al.
Pageof 7